CY1122333T1 - Συνθεσεις διεγερσης βλαστοκυτταρων - Google Patents

Συνθεσεις διεγερσης βλαστοκυτταρων

Info

Publication number
CY1122333T1
CY1122333T1 CY20191101142T CY191101142T CY1122333T1 CY 1122333 T1 CY1122333 T1 CY 1122333T1 CY 20191101142 T CY20191101142 T CY 20191101142T CY 191101142 T CY191101142 T CY 191101142T CY 1122333 T1 CY1122333 T1 CY 1122333T1
Authority
CY
Cyprus
Prior art keywords
wrinkle
defensins
stem cell
cosmetic formulations
topical cosmetic
Prior art date
Application number
CY20191101142T
Other languages
English (en)
Inventor
Nikolay Turovets
William B. ADAMS
Original Assignee
Medicell Technologies, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicell Technologies, Llc filed Critical Medicell Technologies, Llc
Publication of CY1122333T1 publication Critical patent/CY1122333T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)

Abstract

Το αντικείμενο της εφεύρεσης αφορά έτοιμα-προς-χρήση τοπικά καλλυντικά σκευάσματα τα οποία συμπεριλαμβάνουν τουλάχιστον μία ντεφενσίνη που υπάρχει σε υπο-αντιμικροβιακά δραστικές συγκεντρώσεις. Απροσδόκητα, ακόμη και σε τέτοιες χαμηλές συγκεντρώσεις, οι ντεφενσίνες επιστρατεύουν LGR6+ βλαστοκύτταρα από τριχοθυλάκια στον διαθυλακικό χώρο. Συμπεριλαμβάνοντας τις ντεφενσίνες στα εφευρετικά τοπικά καλλυντικά σκευάσματα, είναι δυνατόν να μειώνεται ένα ή περισσότερα από βάθος ρυτίδας, μήκος ρυτίδας, εύρος ρυτίδας, μέγεθος πόρων, ακανόνιστη υφή μιας δερματικής επιφάνειας, λιπαρότητα, καφέ κηλίδες και κόκκινες κηλίδες στο μη τραυματισμένο δέρμα, μειώνοντας έτσι τη φαινομενική ηλικία.
CY20191101142T 2014-06-18 2019-11-01 Συνθεσεις διεγερσης βλαστοκυτταρων CY1122333T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462014044P 2014-06-18 2014-06-18
PCT/US2015/036049 WO2015195677A1 (en) 2014-06-18 2015-06-16 Stem cell stimulating compositions and methods

Publications (1)

Publication Number Publication Date
CY1122333T1 true CY1122333T1 (el) 2021-01-27

Family

ID=54936047

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20191101142T CY1122333T1 (el) 2014-06-18 2019-11-01 Συνθεσεις διεγερσης βλαστοκυτταρων
CY20221100042T CY1125101T1 (el) 2014-06-18 2022-01-18 Συνθεσεις και μεθοδοι διεγερσης βλαστοκυτταρων

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20221100042T CY1125101T1 (el) 2014-06-18 2022-01-18 Συνθεσεις και μεθοδοι διεγερσης βλαστοκυτταρων

Country Status (13)

Country Link
US (5) US11491096B2 (el)
EP (2) EP3586821B1 (el)
CY (2) CY1122333T1 (el)
DK (2) DK3586821T3 (el)
ES (2) ES2903108T3 (el)
HR (2) HRP20211983T1 (el)
HU (1) HUE057737T2 (el)
LT (2) LT3157504T (el)
PL (2) PL3586821T3 (el)
PT (2) PT3586821T (el)
RS (1) RS62981B1 (el)
SI (1) SI3586821T1 (el)
WO (1) WO2015195677A1 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3586821B1 (en) * 2014-06-18 2021-12-01 Medicell Technologies, LLC Stem cell stimulating compositions and methods
SI3389620T1 (sl) 2015-12-15 2023-01-31 Medicell Technologies, Llc Sestavki, ki stimulirajo izvorne celice in postopki zdravljenja melazme
WO2018013142A1 (en) * 2016-07-15 2018-01-18 Medicell Technologies Llc Compositions and methods for providing hair growth
CN109692130B (zh) * 2019-01-30 2022-06-21 威海同丰海洋生物科技有限公司 一种含有防御素的面膜液及其制备方法
CN109718127B (zh) * 2019-01-30 2022-08-09 荣成市吉海生物科技有限公司 一种非离子型杀菌消炎洗面奶及其制备方法
CN109692129B (zh) * 2019-01-30 2022-06-21 威海同丰海洋生物科技有限公司 一种含有防御素的剃须膏及其制备方法
JP6735887B2 (ja) * 2019-08-22 2020-08-05 富士フイルム株式会社 間葉系幹細胞の細胞老化抑制剤、間葉系幹細胞の細胞老化抑制用皮膚外用組成物、間葉系幹細胞の細胞老化抑制用機能性飲食品、及び間葉系幹細胞の細胞老化抑制方法
IT202100018542A1 (it) * 2021-07-14 2023-01-14 Clever Bioscience S R L Liposomi contenenti combinazioni antimicrobiche sinergiche a base di peptidi selezionati e acidi grassi

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3689668A (en) * 1967-10-18 1972-09-05 Emile Leon Piette Method of alleviating wrinkles on skin
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
FR2767832B1 (fr) * 1997-08-29 2001-08-10 Genset Sa Polypeptide defensine humaine def-x, adn genomique et adnc, composition les contenant et applications au diagnostic et au traitement therapeutique
US6984622B2 (en) * 1998-03-25 2006-01-10 The Regents Of The University Of California Use of lipopolysaccharides to manage corneal infections and wounds
EP1519750A2 (en) * 2002-03-28 2005-04-06 Exponential Biotherapies, Inc. Oxygenating agents for enhancing host responses to microbial infections
US8119791B2 (en) * 2003-12-17 2012-02-21 Avon Products, Inc. si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation
DE102005014687A1 (de) * 2005-03-29 2006-10-12 Henkel Kgaa Zusammensetzung enthaltend ß-Defensin 2
US8202835B2 (en) * 2005-06-17 2012-06-19 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
US7528107B2 (en) * 2005-11-30 2009-05-05 Auburn University Methods of treating inflammation in mammalian tissues comprising administering human alpha-defensins
WO2008133928A2 (en) * 2007-04-27 2008-11-06 The Gi Company, Inc. Mucin glycoproteins and their use for treatment of epithelial lesions and mucin dependent disorders
DE102009044970A1 (de) * 2009-07-23 2011-01-27 Henkel Ag & Co. Kgaa Verwendung von humanem beta-Defensin zur Beeinflussung des natürlichen Pigmentierungsprozesses
ES2384060B1 (es) * 2010-03-24 2013-09-23 Lipotec S.A. Cápsulas de nanopartículas lipídicas.
US9034302B2 (en) * 2011-04-11 2015-05-19 L'oreal Mineral sunscreen composition and process for protecting skin from photodamage and aging
WO2012155048A1 (en) * 2011-05-11 2012-11-15 Wisconsin Alumni Research Foundation Liposome-encapsulated hydrogels for use in a drug delivery system
BR112013030874B8 (pt) * 2011-06-02 2021-09-14 Univ California Uso de uma theta-defensina ou análogo da mesma para tratar uma condição inflamatória crônica
US20130310326A1 (en) * 2012-05-18 2013-11-21 Rapid Pathogen Screening, Inc. Histatin for Corneal Wound Healing and Ocular Surface Disease
WO2014004339A2 (en) 2012-06-25 2014-01-03 Elc Management Llc Method for stimulating cellular beta defensins
EP3586821B1 (en) * 2014-06-18 2021-12-01 Medicell Technologies, LLC Stem cell stimulating compositions and methods
SI3389620T1 (sl) * 2015-12-15 2023-01-31 Medicell Technologies, Llc Sestavki, ki stimulirajo izvorne celice in postopki zdravljenja melazme
WO2018013142A1 (en) * 2016-07-15 2018-01-18 Medicell Technologies Llc Compositions and methods for providing hair growth

Also Published As

Publication number Publication date
DK3586821T3 (da) 2022-01-17
EP3157504A4 (en) 2018-01-03
EP3586821A1 (en) 2020-01-01
US20230000750A1 (en) 2023-01-05
US20220401337A1 (en) 2022-12-22
WO2015195677A4 (en) 2016-01-21
CY1125101T1 (el) 2023-06-09
EP3157504A1 (en) 2017-04-26
PL3586821T3 (pl) 2022-03-14
WO2015195677A1 (en) 2015-12-23
RS62981B1 (sr) 2022-03-31
DK3157504T3 (da) 2019-11-04
EP3157504B1 (en) 2019-08-07
US20230000749A1 (en) 2023-01-05
SI3586821T1 (sl) 2022-04-29
US11491096B2 (en) 2022-11-08
PT3586821T (pt) 2022-04-11
EP3586821B1 (en) 2021-12-01
HRP20211983T1 (hr) 2022-08-19
HUE057737T2 (hu) 2022-06-28
US20230000751A1 (en) 2023-01-05
ES2754523T3 (es) 2020-04-20
HRP20191935T1 (hr) 2020-05-15
LT3586821T (lt) 2022-03-25
ES2903108T3 (es) 2022-03-31
PT3157504T (pt) 2019-11-11
PL3157504T3 (pl) 2020-03-31
US20170157015A1 (en) 2017-06-08
LT3157504T (lt) 2019-11-11

Similar Documents

Publication Publication Date Title
CY1122333T1 (el) Συνθεσεις διεγερσης βλαστοκυτταρων
CY1122603T1 (el) Γαμμα-δικετονες για τη θεραπευτικη αντιμετωπιση και την προληψη της γηρανσης του δερματος και των ρυτιδων
BR112017010720A2 (pt) gel aquoso ou alcoólico aquoso de filossilicatos sintéticos como agente de viscosidade, de efeito matificante e/ou agente homogeneizador de aplicação
PH12016501732B1 (en) Formulation for soft anticholinergic analogs
AU2018295515A1 (en) Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes
ZA201902275B (en) Topical dressing composition for the treatment of damaged skin tissue
BR112016024630A2 (pt) composição tópica, uso de uma composição tópica e aplicador
MX2016007760A (es) Uso de alquilamidotiazoles en preparaciones cosmeticas o dermatologicas para la profilaxis y el tratamiento de piel sensible.
UY36248A (es) ?una dispersión a base de agua o aceite, formulaciones y método para prepararlas, y uso de las dispersiones o formulaciones?.
EA201790510A1 (ru) Устройство для местного нанесения материала
MX2015003074A (es) Formulaciones que comprenden idebenona, n-acetil-s-farnesil-l-cist eína y ergotioneína y usos de las mismas.
EP3508191A4 (en) Artificial composition and agent for external application to the skin, as well as cosmetic material using a known artificial composition
CY1122310T1 (el) Εκχυλισμα γαρδενιας για τον χρωματισμο του δερματος
AR101581A1 (es) Composición de colutorio
BR112018073862A2 (pt) composição para cuidado dos cabelos
NZ715905A (en) Compositions and methods for treating skin
PL3478368T3 (pl) Kompozycja do zwalczania oznak starzenia się skóry oraz przydatków skóry
BR112016029996A2 (pt) utilização cosmética, composição e método cosmético para tratar os odores corporais
MX2020007894A (es) Carbonato de calcio tratado mediante reaccion superficial para modificar las propiedades biomecanicas de la piel.
CL2018001104A1 (es) Composición para el cuidado de la piel y procedimiento asociado.
CY1123360T1 (el) Ενωσεις oi οποιες εχουν αντιοξειδωτικη δραση εναντι των ελευθερων ριζων και αντιφλεγμονωδη δραση, και αντιστοιχες φαρμακευτικες συνθεσεις για τη φροντιδα του δερματος
NZ746011A (en) Glycoalkaloid combinations and various uses thereof
MX2019011951A (es) Secretoma bacteriano para usarse en el tratamiento contra lesiones cutaneas.
BR112015026588A2 (pt) uso cosmético, composição e método cosmético
MX2015016553A (es) Composiciones cosmeticas o dermatologicas que combinan cosmeticos de retinaldehido y de oleamida de glicilglicina y los usos cosmeticos o dermatologicos de los mismos.